NASDAQ:AZRX - AzurRx BioPharma Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$2.16 +0.02 (+0.93 %)
(As of 05/24/2019 04:00 PM ET)
Previous Close$2.16
Today's Range$2.10 - $2.19
52-Week Range$1.00 - $3.75
Volume51,057 shs
Average Volume97,322 shs
Market Capitalization$45.49 million
P/E RatioN/A
Dividend YieldN/A
Beta2.98

Analyst Ratings

AzurRx BioPharma (NASDAQ:AZRX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for AzurRx BioPharma in the last 12 months. Their average twelve-month price target is $7.30, suggesting that the stock has a possible upside of 237.96%. The high price target for AZRX is $10.50 and the low price target for AZRX is $5.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $7.30$7.30$7.10$6.6667
Price Target Upside: 237.96% upside180.77% upside253.23% upside210.08% upside

AzurRx BioPharma (NASDAQ:AZRX) Consensus Price Target History

Price Target History for AzurRx BioPharma (NASDAQ:AZRX)

AzurRx BioPharma (NASDAQ:AZRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/24/2019HC WainwrightReiterated RatingBuyLowView Rating Details
4/24/2019Maxim GroupReiterated RatingBuy$5.00LowView Rating Details
2/26/2019OppenheimerSet Price TargetBuy$8.00LowView Rating Details
1/25/2019Roth CapitalInitiated CoverageBuy$10.50HighView Rating Details
10/17/2018CIBCInitiated CoverageOutperform ➝ Outperform$6.00HighView Rating Details
(Data available from 5/25/2017 forward)
This page was last updated on 5/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel